BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 18436012)

  • 21. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of the sentinel lymph node procedure in patients with large size breast cancer.
    Lelievre L; Houvenaeghel G; Buttarelli M; Brenot-Rossi I; Huiart L; Tallet A; Tarpin C; Jacquemier J
    Ann Surg Oncol; 2007 Feb; 14(2):621-6. PubMed ID: 17103062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection.
    Veronesi U; Galimberti V; Mariani L; Gatti G; Paganelli G; Viale G; Zurrida S; Veronesi P; Intra M; Gennari R; Rita Vento A; Luini A; Tullii M; Bassani G; Rotmensz N
    Eur J Cancer; 2005 Jan; 41(2):231-7. PubMed ID: 15661547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
    Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
    Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection.
    Calhoun KE; Hansen NM; Turner RR; Giuliano AE
    Am J Surg; 2005 Oct; 190(4):588-91. PubMed ID: 16164927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.
    Cox C; White L; Allred N; Meyers M; Dickson D; Dupont E; Cantor A; Ly Q; Dessureault S; King J; Nicosia S; Vrcel V; Diaz N
    Ann Surg Oncol; 2006 May; 13(5):708-11. PubMed ID: 16538416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
    Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
    Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node metastasis in patients with frozen section analyses that are negative for tumors.
    Lee SK; Lee KW; Kim S; Choi MY; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Lee JE; Yang JH; Nam SJ
    Oncology; 2012; 83(1):31-7. PubMed ID: 22722529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The changing landscape of axillary surgery: which breast cancer patients may still benefit from complete axillary lymph node dissection?
    McGhan LJ; Dueck AC; Gray RJ; Wasif N; McCullough AE; Pockaj BA
    J Surg Oncol; 2012 Sep; 106(3):254-9. PubMed ID: 22034211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
    Davit FE; Gatmaitan P; Garguilo G
    Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of three scoring systems predicting non sentinel node metastasis in breast cancer patients with a positive sentinel node biopsy.
    Dauphine CE; Haukoos JS; Vargas MP; Isaac NM; Khalkhali I; Vargas HI
    Ann Surg Oncol; 2007 Mar; 14(3):1014-9. PubMed ID: 17176986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
    Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
    Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.
    Motomura K; Egawa C; Komoike Y; Nagumo S; Koyama H; Inaji H
    Ann Surg Oncol; 2006 Jul; 13(7):985-9. PubMed ID: 16788761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymphadenectomy for breast cancer in a community managed care setting.
    Guenther JM; Krishnamoorthy M; Tan LR
    Cancer J Sci Am; 1997; 3(6):336-40. PubMed ID: 9403045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node biopsy in patients with previous ipsilateral complete axillary lymph node dissection.
    Kaur P; Kiluk JV; Meade T; Ramos D; Koeppel W; Jara J; King J; Cox CE
    Ann Surg Oncol; 2011 Mar; 18(3):727-32. PubMed ID: 20593244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.